Jul 2025 $1 M No. 6 Under $2 million 17
Cyrus Biotechnology, Inc.: Raise no. 6, Jul 2025 × Investors in this round 17 investors had bought by the notice of May 8, 2026: 17 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $3 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Lucas Nivon · Executive Officer, Director Mark Benjamin · Executive Officer Anthony Manning · Director Chad Waite · Director Jason Smith · Director Ramakrishna Satyavolu · Director Yifan Song · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Lucas Nivon, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed May 8, 2026. Read the notice at the SEC .
options SEC Oct 2024 $3 M No. 5 $2 to $10 million 27
Cyrus Biotechnology, Inc.: Raise no. 5, Oct 2024 × Investors in this round 27 investors had bought by the notice of Dec 31, 2024: 27 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $4 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Lucas Nivon · Executive Officer, Director Mark Benjamin · Executive Officer Anthony Manning · Director Chad Waite · Director Jason Smith · Director Ramakrishna Satyavolu · Director Yifan Song · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Lucas Nivon, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 31, 2024. Read the notice at the SEC .
options SEC Feb 2024 $3 M No. 4 $2 to $10 million 33
Cyrus Biotechnology, Inc.: Raise no. 4, Feb 2024 × Investors in this round 33 investors had bought by the notice of Feb 29, 2024: 33 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $4 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Lucas Nivon · Executive Officer, Director Mark Benjamin · Executive Officer Chad Waite · Director Yifan Song · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Lucas Nivon, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 29, 2024. Read the notice at the SEC .
debt, options SEC Jun 2021 $18 M No. 3 $10 to $50 million 34
Cyrus Biotechnology, Inc.: Raise no. 3, Jun 2021 × Investors in this round 34 investors had bought by the notice of Dec 2, 2021: 34 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $18 M of $19 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Lucas Nivon · Executive Officer, Director Mark Benjamin · Executive Officer Yifan Song · Executive Officer, Director Chad Waite · Director Gus Tai · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Lucas Nivon, Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed Dec 2, 2021. Read the notice at the SEC .
equity SEC Jul 2017 $8 M No. 2 $2 to $10 million 18
Cyrus Biotechnology, Inc.: Raise no. 2, Jul 2017 × Investors in this round 18 investors had bought by the notice of Jul 27, 2017: 18 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $8 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Javier Castellanos · Executive Officer Lucas Nivon · Executive Officer, Director Yifan Song · Executive Officer, Director Chad Waite · Director Eric Bell · Director Gus Tai · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Lucas Nivon, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 27, 2017. Read the notice at the SEC .
equity SEC Feb 2017 $1 M No. 1 Under $2 million 13
Cyrus Biotechnology, Inc.: Raise no. 1, Feb 2017 × Investors in this round 13 investors had bought by the notice of Feb 21, 2017: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Javier Castellanos · Executive Officer, Director, Promoter Lucas Nivon · Executive Officer, Director, Promoter Yifan Song · Executive Officer, Director, Promoter Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Lucas Nivon, Ceo. Source: SEC Form D, newest notice filed Feb 21, 2017. Read the notice at the SEC .
equity SEC